671777-40-5

Basic information

• Product Name: (5R)-5-(2, 2-DIMETHVL-4H-1, 3-BENZODIOXIN-6-VL)-3-F₆-R₄-(3-IODOPHENVL) BUTOXVLHEXVL-1, 3-oxazolidin-2-one
• Synonyms: (5R)-5-(2, 2-DIMETHVL-4H-1, 3-BENZODIOXIN-6-VL)-3-F₆-R₄-(3-IODOPHENVL) BUTOXVLHEXVL-1, 3-oxazolidin-2-one
• CAS NO: 671777-40-5
• Molecular Weight: 607.529
• Mol File: 671777-40-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (5R)-5-(2, 2-DIMETHVL-4H-1, 3-BENZODIOXIN-6-VL)-3-F₆-R₄-(3-IODOPHENVL) BUTOXVLHEXVL-1, 3-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (5R)-5-(2, 2-DIMETHVL-4H-1, 3-BENZODIOXIN-6-VL)-3-F₆-R₄-(3-IODOPHENVL) BUTOXVLHEXVL-1, 3-oxazolidin-2-one(671777-40-5)
• EPA Substance Registry System: (5R)-5-(2, 2-DIMETHVL-4H-1, 3-BENZODIOXIN-6-VL)-3-F₆-R₄-(3-IODOPHENVL) BUTOXVLHEXVL-1, 3-oxazolidin-2-one(671777-40-5)

Safety Data

• Hazardous Substances Data: 671777-40-5(Hazardous Substances Data)

Upstream product

• 452339-73-0 (5R)-5-(2,2-dimethyl- 4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one 

Downstream Products

• 686350-94-7 (5R)-3-(6-{4-[3-(cyclopentylthio)phenyl]butoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one 
• 688798-01-8 methyl (2E)-3-{3'-[4-({6-[(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxo-1,3-oxazolidin-3-yl]hexyl}oxy)butyl]-1,1'-biphenyl-3-yl}prop-2-enoate 
• 688798-23-4 (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-3-(6-{4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]butoxy}hexyl)-1,3-oxazolidin-2-one 

Relevant articles and documents

PHENETHANOLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.

PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to novel compounds of formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.